Top stories
Dr. Dennis L Citrin MD
USINFO | 2013-11-28 15:08
Medical Oncologist
Contact Information
2361 Paysphere Cir
Chicago, IL 60674
Phone: (847) 746-4358
Specialty & Clinical Interests
Medical Oncologist: General Oncology
Hospital Affiliation
Midwestern Regional Medical Center
Education & Medical Training
University of Wisconsin
Fellowship, Medical Oncology, 1976 - 1977
University of Glasgow Faculty of Medicine
Class of 1969
Certifications & Licensure
American Board of Internal Medicine
Certified 2014 years in Internal Medicine
American Board of Internal Medicine
Certified 2014 years in Medical Oncology
IL State Medical License
Active through 2014
Publications & Presentations
Beliefs and Perceptions of Women with Newly Diagnosed Breast Cancer Who Refused Conventional Treatment in Favor of Alternative Therapies.
Citrin, D. L., Bloom, D. L., Grutsch, J. F., Mortensen, S. J., Lis, C. G.
Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinibmonotherapy.
Johnston, S., Trudeau, M., Kaufman, B., Boussen, H., Blackwell, K., LoRusso, P., Lombardi, D.P., Ben Ahmed, S., Citrin, D.L., DeSilvio, M.L., Harris, J., Westlund, R.E., Salazar, V., Zaks, T.Z., Spector, N.L.
Contact Information
2361 Paysphere Cir
Chicago, IL 60674
Phone: (847) 746-4358
Specialty & Clinical Interests
Medical Oncologist: General Oncology
Hospital Affiliation
Midwestern Regional Medical Center
Education & Medical Training
University of Wisconsin
Fellowship, Medical Oncology, 1976 - 1977
University of Glasgow Faculty of Medicine
Class of 1969
Certifications & Licensure
American Board of Internal Medicine
Certified 2014 years in Internal Medicine
American Board of Internal Medicine
Certified 2014 years in Medical Oncology
IL State Medical License
Active through 2014
Publications & Presentations
Beliefs and Perceptions of Women with Newly Diagnosed Breast Cancer Who Refused Conventional Treatment in Favor of Alternative Therapies.
Citrin, D. L., Bloom, D. L., Grutsch, J. F., Mortensen, S. J., Lis, C. G.
Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinibmonotherapy.
Johnston, S., Trudeau, M., Kaufman, B., Boussen, H., Blackwell, K., LoRusso, P., Lombardi, D.P., Ben Ahmed, S., Citrin, D.L., DeSilvio, M.L., Harris, J., Westlund, R.E., Salazar, V., Zaks, T.Z., Spector, N.L.
